Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products, Inc. (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.295 per share, payable on April 4, 2023, to shareholders recorded by close of business on March 17, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Utah Medical Products, Inc. (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.295 per share, payable on April 4, 2023, to shareholders recorded by close of business on March 17, 2023. This marks a 1.7% increase compared to the same period last year. The company specializes in medical devices for women and babies, with products recognized globally for optimal patient outcomes. For more details on Utah Medical Products, Inc., visit www.utahmed.com.
Positive
- Quarterly dividend of $0.295 per share, indicating shareholder returns.
- 1.7% increase in dividend compared to the previous year, showing financial growth and confidence.
Negative
- None.
Details
News Market Reaction – UTMD
The recorded move for UTMD in the trading session of this news was +1.46%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESSWIRE / February 7, 2023 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on April 4, 2023 to shareholders of record at the close of business on March 17, 2023. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact: Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View source version on accesswire.com:
https://www.accesswire.com/738261/Utah-Medical-Products-Inc-Announces-Quarterly-Dividend
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.